Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1.39B
-
Number of holders
-
194
-
Total 13F shares, excl. options
-
46.9M
-
Shares change
-
-717K
-
Total reported value, excl. options
-
$8.37B
-
Value change
-
-$143M
-
Put/Call ratio
-
4.88
-
Number of buys
-
85
-
Number of sells
-
-102
-
Price
-
$178.30
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q2 2023
248 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q2 2023.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 194 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.9M shares
of 1.39B outstanding shares and own 3.39% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (11.7M shares), Capital International Investors (6.3M shares), HHLR ADVISORS, LTD. (5.18M shares), PRIMECAP MANAGEMENT CO/CA/ (5.01M shares), BAILLIE GIFFORD & CO (3.28M shares), Temasek Holdings (Private) Ltd (3.01M shares), FMR LLC (2.28M shares), Invesco Ltd. (1.56M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.48M shares), and Capital International, Inc./CA/ (919K shares).
This table shows the top 194 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.